Authors: Chuntharapai, A Dodge, K Grimmer, K Schroeder, K Marsters, SA Koeppen, H Ashkenazi, A Kim, KJ

Citation: A. Chuntharapai et al., Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4, J IMMUNOL, 166(8), 2001, pp. 4891-4898

Authors: Wu, Y Dowbenko, D Pisabarro, MT Dillard-Telm, L Koeppen, H Lasky, LA

Citation: Y. Wu et al., PTEN 2, a Golgi-associated testis-specific homologue or the PTEN tumor suppressor lipid phosphatase, J BIOL CHEM, 276(24), 2001, pp. 21745-21753

Authors: Shou, JY Ross, S Koeppen, H de Sauvage, FJ Gao, WQ

Citation: Jy. Shou et al., Dynamics of notch expression during murine prostate development and tumorigenesis, CANCER RES, 61(19), 2001, pp. 7291-7297

Authors: Ross, S Spencer, SD Lasky, LA Koeppen, H

Citation: S. Ross et al., Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model ofprostate carcinogenesis, AM J PATH, 158(3), 2001, pp. 809-816

Authors: Stoffel, A Rao, PH Louie, DC Krauter, K Liebowitz, DN Koeppen, H Le Beau, MM Chaganti, RSK

Citation: A. Stoffel et al., Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC, GENE CHROM, 24(2), 1999, pp. 156-159

Authors: Ashkenazi, A Pai, RC Fong, S Leung, S Lawrence, DA Masters, SA Blackie, C Chang, L McMurtrey, AE Hebert, A DeForge, L Koumenis, IL Lewis, D Harris, L Bussiere, J Koeppen, H Shahrokh, Z Schwall, RH

Citation: A. Ashkenazi et al., Safety and antitumor activity of recombinant soluble Apo2 ligand, J CLIN INV, 104(2), 1999, pp. 155-162